Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mayne Pharma Group ( (AU:MYX) ) has shared an update.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Mayne Pharma Group Limited as of July 1, 2025. This change in substantial holding is due to the purchase of securities by an entity controlled by Morgan Stanley, impacting the voting securities associated with Mitsubishi UFJ Financial Group.
The most recent analyst rating on (AU:MYX) stock is a Hold with a A$7.40 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 923,378
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$406.2M
For an in-depth examination of MYX stock, go to TipRanks’ Overview page.